BMI1 and central nervous system cancer: The treatment of glioma cells with cyclopamine, GANT61 or siRNA against GLI1, GLI2, or GLI3 significantly decreased the expression of GLI1, FOXM1, BMI1, SOX2, and OCT4, involving in the maintenance of the stem cell state.